Free Trial
NASDAQ:SRZN

Surrozen (SRZN) Stock Price, News & Analysis

Surrozen logo
$9.56 +0.53 (+5.87%)
Closing price 04:00 PM Eastern
Extended Trading
$9.59 +0.03 (+0.26%)
As of 05:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Surrozen Stock (NASDAQ:SRZN)

Key Stats

Today's Range
$9.11
$9.95
50-Day Range
$8.13
$11.00
52-Week Range
$5.90
$18.17
Volume
10,258 shs
Average Volume
11,484 shs
Market Capitalization
$81.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$38.50
Consensus Rating
Buy

Company Overview

Surrozen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

SRZN MarketRank™: 

Surrozen scored higher than 52% of companies evaluated by MarketBeat, and ranked 729th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Surrozen has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Surrozen has only been the subject of 1 research reports in the past 90 days.

  • Read more about Surrozen's stock forecast and price target.
  • Earnings Growth

    Earnings for Surrozen are expected to decrease in the coming year, from ($8.49) to ($10.71) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Surrozen is -0.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Surrozen is -0.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Surrozen's valuation and earnings.
  • Percentage of Shares Shorted

    1.62% of the float of Surrozen has been sold short.
  • Short Interest Ratio / Days to Cover

    Surrozen has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Surrozen has recently increased by 7.75%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Surrozen does not currently pay a dividend.

  • Dividend Growth

    Surrozen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.62% of the float of Surrozen has been sold short.
  • Short Interest Ratio / Days to Cover

    Surrozen has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Surrozen has recently increased by 7.75%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Surrozen has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Surrozen this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added Surrozen to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Surrozen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    45.18% of the stock of Surrozen is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    66.57% of the stock of Surrozen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Surrozen's insider trading history.
Receive SRZN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surrozen and its competitors with MarketBeat's FREE daily newsletter.

SRZN Stock News Headlines

Surrozen Reports Q2 Profit on Gains
FOUR TRILLION DOLLARS!
Nvidia just became the first company in history to hit a $4 trillion valuation—surpassing Apple and Microsoft. But one controversial analyst, known for predicting the collapses of Fannie Mae, GM, and others, is issuing a serious warning. He believes Nvidia’s rise has masked a dangerous flaw—and that the stock could fall 50% or more from current levels.
Surrozen to Present at Upcoming Healthcare Investor Conference
See More Headlines

SRZN Stock Analysis - Frequently Asked Questions

Surrozen's stock was trading at $14.35 at the beginning of 2025. Since then, SRZN stock has decreased by 33.4% and is now trading at $9.56.

Surrozen, Inc. (NASDAQ:SRZN) issued its earnings results on Friday, August, 8th. The company reported ($1.14) EPS for the quarter, topping the consensus estimate of ($1.23) by $0.09.

Surrozen's stock reverse split on Thursday, December 14th 2023.The 1-15 reverse split was announced on Thursday, December 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Surrozen's top institutional investors include Geode Capital Management LLC (0.36%). Insiders that own company stock include Group Gp Lp Column III, Tim Kutzkey, Yang Li and Charles O Williams.
View institutional ownership trends
.

Shares of SRZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Surrozen investors own include ACADIA Pharmaceuticals (ACAD), Marvell Technology (MRVL), HubSpot (HUBS), Avidity Biosciences (RNA), Adverum Biotechnologies (ADVM), Alpha and Omega Semiconductor (AOSL) and

Company Calendar

Today
8/08/2025
Last Earnings
8/08/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SRZN
CIK
1824893
Fax
N/A
Employees
80
Year Founded
N/A

Price Target and Rating

High Price Target
$45.00
Low Price Target
$32.00
Potential Upside/Downside
+302.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($24.96)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.56 million
Net Margins
N/A
Pretax Margin
-702.04%
Return on Equity
-842.90%
Return on Assets
-71.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.02
Quick Ratio
10.02

Sales & Book Value

Annual Sales
$10.65 million
Price / Sales
7.68
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($6.55) per share
Price / Book
-1.46

Miscellaneous

Outstanding Shares
8,560,000
Free Float
4,694,000
Market Cap
$81.83 million
Optionable
Not Optionable
Beta
0.60

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:SRZN) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners